Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) EPS (Basic) (2016 - 2025)

Dexcom (DXCM) has disclosed EPS (Basic) for 16 consecutive years, with $0.69 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 81.58% to $0.69 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.15 through Dec 2025, up 47.26% year-over-year, with the annual reading at $2.14 for FY2025, 46.58% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.69 at Dexcom, down from $0.73 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.73 in Q3 2025, with the low at -$0.01 in Q4 2021.
  • Average EPS (Basic) over 5 years is $0.34, with a median of $0.3 recorded in 2023.
  • The sharpest move saw EPS (Basic) plummeted 69.33% in 2021, then surged 2500.0% in 2022.
  • Over 5 years, EPS (Basic) stood at -$0.01 in 2021, then soared by 2500.0% to $0.24 in 2022, then skyrocketed by 175.0% to $0.66 in 2023, then plummeted by 42.42% to $0.38 in 2024, then soared by 81.58% to $0.69 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $0.69, $0.73, and $0.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.